SFX by Ex Libris Inc.

Title:	Sub-chronic exposure to fluoxetine in juvenile oysters (Crassostrea gigas): uptake and biological effects
Source:	Environmental Science and Pollution Research [0944-1344] Di Poi, Carole yr:2014

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ford, Alex T. "The effects of antidepressants appear to be rapid and at environmentally relevant concentrations." Environmental toxicology and chemistry 35.4 (2015): 794-798.
description	2.	Ballandonne, H. "Toxicities of 48 pharmaceuticals and their freshwater and marine environmental assessment in northwestern France." Environmental science and pollution research international 23.6 (2014): 4992-5001.
description	3.	Fournier, F. "Effects of short-term exposure to environmentally relevant concentrations of different pharmaceutical mixtures on the immune response of the pond snail Lymnaea stagnalis." Science of the total environment 445-446.C (2013): 210-218.
description	4.	Johnson, David J. "Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae." Ecotoxicology and environmental safety 67.1 (2007): 128-139.
description	5.	NaÅÄcz-Jawecki, G. "Evaluation of the in vitro biotransformation of fluoxetine with HPLC, mass spectrometry and ecotoxicological tests." Chemosphere 70.1 (2007): 29-35.
description	6.	Nałȩcz-Jawecki, G. "Evaluation of in vitro biotransformation of propranolol with HPLC, MS/MS, and two bioassays." Environmental toxicology 23.1 (2008): 52-58.
description	7.	Brooks, Duane B W. "Waterborne and sediment toxicity of fluoxetine to select organisms." Chemosphere 52.1 (2003): 135-42.
description	8.	Crane, M. "Chronic aquatic environmental risks from exposure to human pharmaceuticals." The Science of the total environment 367.1 (2006): 23-41.
description	9.	Varano, V. "Assessing the environmental hazard of individual and combined pharmaceuticals: acute and chronic toxicity of fluoxetine and propranolol in the crustacean Daphnia magna." Ecotoxicology 26.6 (2017): 1-18.
description	10.	Istanbulluoglu, H. "Pharmaceutical pollution in water." TAF Preventive Medicine Bulletin 15.4 (2016): 467-472.
description	11.	Miller, Elizabeth L. "Root Uptake of Pharmaceuticals and Personal Care Product Ingredients." Environmental science & technology 50.2 (2016): 525-541.
description	12.	Watanabe, H. "Chronic toxicity of an environmentally relevant mixture of pharmaceuticals to three aquatic organisms (alga, daphnid, and fish)." Environmental Toxicology and Chemistry 35.4 (2016): 996-1006.
description	13.	Godoy, A. "Occurrence, ecotoxicological effects and risk assessment of antihypertensive pharmaceutical residues in the aquatic environment - A review." Chemosphere 138.C (2015): 281-91.
description	14.	Axelle, C. "Psychotropic drugs in mixture alter swimming behaviour of Japanese medaka (Oryzias latipes) larvae above environmental concentrations." Environmental science and pollution research international 23.6 (2014): 4964-4977.
description	15.	Sibley, R.S. K. "Human health risk assessment of pharmaceuticals and personal care products in plant tissue due to biosolids and manure amendments, and wastewater irrigation." Environment international 75C.C (2014): 223-233.
description	16.	Verlicchi, P. "Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment-A review." Science of the total environment 429 (2012): 123-155.
description	17.	Meredith Williams, M. "Uptake and depuration of pharmaceuticals in aquatic invertebrates." Environmental pollution 165 (2012): 250-258.
description	18.	Ghosh, J. "Invertebrate Immune Diversity." Developmental & comparative immunology 35.9 (2010): 959-974.
description	19.	Oakes, Ken D. "Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework." Integrated environmental assessment and management 6.Suppl. 1, Sp. Iss. SI (2010): 524-539.
description	20.	Christen, V. "Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action." Aquatic Toxicology 96.3 (2010): 167-181.